New treatment approaches for Merkel cell carcinoma - checkpoint inhibitors
Design and results of Phase III FALCON trial of fulvestrant for advanced breast cancer
Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials
How can durvalumab be used in NSCLC?
The importance of Wnt signalling in melanoma